Neurimmune Holding
Fabian Buller has a strong background in biotech business development, with experience in identifying new partners for biologics technology and drug discovery programs. Fabian has held various roles at companies like Neurimmune AG, Johnson & Johnson, and Covagen AG. Additionally, Fabian has an educational background in chemistry and biophysical chemistry from institutions such as ETH Zurich and University of Münster.
Neurimmune Holding
Neurimmune develops innovative immunotherapeutics for human diseases.